PPARγ plays a crucial role in IPF progression, and its anti-fibrotic effects are mediated through multiple mechanisms, including modulation of the Smad pathway to inhibit the pro-fibrotic signal of TGF-β [45]. Here, PPARG is linked to idiopathic pulmonary fibrosis.